Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

The FDA took a step to crack down on compounded GLP-1s, but it's not exactly a win for Novo Nordisk and Eli Lilly. Meanwhile, ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Tribeca Studios has launched a new incubator program, which aims to empower rising filmmakers to more earnestly portray diseases and health-related stories on-screen. Tribeca created the program in ...

The restructuring, which would eliminate 11% of the company's workforce, aimed to reduce organizational complexity and speed ...

US pharmaceutical company Eli Lilly and Company has reaffirmed its strong commitment to advancing healthcare in China by ...

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

Novo Nordisk , the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to ...

The Danish pharmaceutical giant, which is looking to revive growth, used to be Europe's most valuable company listed on ...

The Danish pharma giant outlined proposals to shed around 11% of its 78,400-strong workforce amid stiff competition from ...

Novo Nordisk is cutting 9,000 jobs to save $1.25 billion annually and reignite growth. Facing competition from Eli Lilly, the ...